Jan 13 (Reuters) - KALYTERA THERAPEUTICS INC KALY.V
* KALYTERA THERAPEUTICS ENTERS INTO BINDING LETTER OF INTENT TO ACQUIRE TALENT BIOTECHS AND ITS PHASE 2 CLINICAL-STAGE GRAFT VERSUS HOST DISEASE PROGRAM
* UNDER TERMS OF LOI, KALYTERA HAS MADE A NON-REFUNDABLE PAYMENT OF USD$1 MILLION TO TALENT SOURCE TEXT FOR EIKON: ID:nCCN9fs8gb FURTHER COMPANY COVERAGE: KALY.V